iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
83 hedge funds and large institutions have $98.2M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.57% more ownership
Funds ownership: 26.71% → 27.28% (+0.57%)
Holders
83
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.4M | |
| 2 | +$2.3M | |
| 3 | +$1.13M | |
| 4 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$1.07M |
| 5 |
Morgan Stanley
New York
|
+$1.03M |
Top Sellers
| 1 | -$9.1M | |
| 2 | -$8.64M | |
| 3 | -$747K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$391K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$372K |